Filtration system Pall Corporation reported its first quarter
earnings which revealed earnings rose by 16 per cent, propelled by
growth in its industrial and biopharmaceuticals segments.
Invitrogen has created three new business divisions in a move to
strengthen its position in the growing biotechnology industry and
drive growth through improving links between its product
development cycle and customer base.
According to a new report, the demand for worldwide drug packaging
is expected to reach new heights, predicting growth of 5.3 per cent
annually to $24.3 billion (€20 7 billion) in 2009, driven by aging
demographic patterns increasing...
As low-cost contract manufacturing organisations (CMO) in Asia are
becoming more attractive to drug companies, Western CMOs are having
to develop new business strategies in order to compete.
A new algorithm, which automatically selects molecule images for
crystallisation in Silico studies, is set to advance laboratory
studies by increasing the speed and power of methods for
determining biological structures at high resolution,...
Accelovance has broadened its presence in China and expanded its
capacity for conducting Phase I-IV clinical trials for Western
pharmaceutical and biotech firms seeking to enter the Chinese
market, by opening a new office in Shanghai.
After a two-year tug-of-war, the World Trade Organization (WTO) has
solidified a landmark agreement to allow poor nations to import
generic versions of patented drugs to treat serious diseases or
epidemics.
Domantis has announced an alliance with pharma giants Bristol-Myers
Squibb to develop human Domain Antibody (dAb) products, a novel
approach to address therapeutic targets involved in T-cell
co-stimulation.
The question as to why some cancers resist drugs could be answered
by the discovery of new mechanisms, which delve deeper into how
cancer cells evolve to become resistant to various chemotherapy
drugs.
A dairy based vaccine could soon be on the horizon after
researchers took a giant step in the development of a series of
effective cancer-fighting vaccines that appear to be able to stop
and reverse cancer growth.
Stratagene announces a molecular diagnostics agreement, which aims
to focus on the growing molecular diagnostics market for infectious
diseases, currently worth $6.5 billion (€5.5 billion), expanding to
$12 billion by 2010 driven...
Researchers believe that they have identified a drug target
molecule that could be used to treat mental impairment in people
with Down's syndrome paving the way for a treatment that could
improve the quality of life for sufferers.
Aegate will launch a software solution to combat one of the
pharmaceutical industry's biggest and growing patient safety issues
- counterfeit drugs - in the UK, US and Belgium in 2006 following
the recent success of its UK pilot...
Grunenthal has developed a novel method of delivering drugs to
children in the form of a drinking straw, which is set to provide a
solution to administering treatment to patients who cannot tolerate
unpleasant tasting drugs.
Baxa Corporation launches its medication validation system that
validates narcotic returns and identifies counterfeit medications.
The system also offers validation of medication to ensure the type
and strength of high-risk medications.
BASF has announced that it is to raise prices of its pharmaceutical
excipients in a move that represents the wider market that has seen
big cost increases for raw materials, energy and transportation
that has affected all excipient...
Clinical research organisation, Covalent Group, has agreed with
Emergent BioSolutions to develop immune globulins for treatment
exposure of anthrax infection, signifying another step in the
worldwide drive to bring an effective treatment...
Clinical trials service provider, The Specials Clinical
Manufacturing, has announced the recent installation of Isopak's
In-Cap machine, an automatic bench machine that is currently the
smallest automatic filling machine in the...
Escalating drug costs could be driven down by up to $20 billion a
year and dwindling drug pipelines improved if a newly-formed US
research group is successful.
Carrington Laboratories has been granted a European patent for its
drug and vaccine delivery technology, representing the first
European Patent issued for the company's GelSite Polymer, designed
for peptide and protein-based...
A novel drug delivery system that allows hospital patients to
self-administer pain relief medication without an intravenous line
could be available in the US within six months, pending final Food
and Drug Administration (FDA) approval.
Omron Corp aims to invest $20 million in the next two years in an
attempt to capture a larger slice of the RFID market, which is
expected to swell from $1.95 billion (€1.65 million) in 2005 to an
estimated $26.9 billion in 2015, driven...
Laboratory researchers believe that a recent discovery will prove
highly effective in stopping the progress of anthrax infection,
further developing reliable treatments to diagnose this killer
microorganism.
A Strategic Research Agenda (SRA) was launched last week in a move
to bolster the chemistry and biotechnology industry's contribution
to European growth and competitiveness.
A new report suggests that up to 30 biopharmaceutical products
developed by UK companies using cell-based manufacturing techniques
could be approved by 2012, reinforcing the idea that
biopharmaceuticals are increasingly being seen...
Researchers believe that new treatments or ways to diagnose memory
problems will get a boost from a substantial grant that aims to
create a brain-scanning method to test drug treatments, which
investigates how brain cells age, and...
Roche and BioCryst Pharmaceuticals announced an agreement to
develop and commercialise BioCryst's phase I compound, which has
been developed for the prevention of acute rejection in
transplantation and for the treatment of autoimmune...
Gentra Systems has introduced its new versaGene DNA Cell
Purification Kit, which responds to the growing need for
high-quality DNA for sensitive downstream applications. The kit
uses chemistry and column design to purify DNA with...
Oxford University has been given the go-ahead to resume building
work on its new animal research laboratory complex, which had
previously been the subject of protest from animal rights activists
last summer.
An automated prescription verification process is proving a
valuable tool for the prevention of drug dispensing errors and is
now gaining acceptance within the US pharmacy industry.
Researchers have developed a new laboratory technique, which allows
them to change sequences within a DNA molecule. The tool is set to
have positive implications in DNA lab-based medical diagnosis and
nanobiotechnology.
Bentley has accelerated the path to launching its novel intranasal
spray insulin, signing a license agreement with India's Biocon to
develop and market the product in 85 countries throughout Asia,
Africa, and the Middle East.
Merck is to cut 7,000 jobs, close five factories and three research
facilities, as the US pharmaceutical company continues to suffer
from the devastating repercussions caused by its painkiller Vioxx
and the pending lawsuits.
Schott Pharmaceutical Packaging will be the first international
manufacturer of primary pharmaceutical glass packaging to establish
a production site in China, in a move that will increase supply to
Chinese injectable drug manufacturers...
Hopax Fine Chemicals is building a new facility in Kaohsiung,
Taiwan, in a move to raise current production capacity by five
folds and become one of the top providers for biological buffers
and specialty chemicals for the pharmaceutical...
Bayer Diagnostics launches its latest immunoassay system, part of
its ADVIA family of automated clinical laboratory solutions, which
enable laboratories to rapidly perform a wide variety of
disease-specific tests which enhance the...
The pressures placed on pharmaceutical and biotechnology firms are
causing companies to outsource their drug discovery processes as
contract research organisations (CROs) expand to offer services
such as finance/accounting, logistics...
Cellectricon has launched a new chip for safety pharmacology and
hERG studies, which aims to provide a solution to the current need
for increased throughput and data quality in ion channel drug
discovery that has plagued drug researchers.
Gedeon Richter and Forest Laboratories have expanded their
collaboration by forming two additional agreements involving two
novel mechanisms targeted for the treatment of CNS conditions,
building upon the existing collaboration announced...
SemBioSys Genetics has demonstrated bio-equivalence of a
plant-produced insulin, which if realised, could become a viable
alternative to meet the demand for insulin as the incidence of
diabetes increases worldwide.
Researchers have developed a new catalyst process that offers
faster reaction rates, a substantially higher product yield and a
cleaner production process than is currently available in the
pharmaceutical and chemical industry.
Alcan has acquired the outstanding minority share of Propack in a
deal that further cements the company's standing in the Chinese
market. The acquisition forms part of a major restructuring
exercise, in which the closure and...
The world's first commercial-scale continuous sonocrystallisation
system promises to revolutionise the way crystals are processed in
pharmaceutical manufacturing.
Private equity firm, Direct Capital has acquired a shareholding of
51 per cent in New Zealand Pharmaceuticals (NZP). The investment by
Direct Capital aims to tap into the growing potential of
glycotherapeutics drugs.
Isopak have launched a new semi automatic capsule-filling machine
that is designed to deal with non-lubricated substances intended
for clinical trials, and drug or product development work.
BASF launched its new dry binder excipient at CPhI, aimed at
increasing the hardness of pharmaceutical tablets and reducing the
manufacturing costs associated with damaged and broken tablets.
A US district court has denied a motion by Bio-Rad Laboratories to
enforce an alleged settlement agreement with Applied Biosystems
meaning the life science research product provider cannot continue
selling its thermal cycler products.
Researchers have identified two proteins involved in the process
that controls plant growth, which may help explain why human cells
reject chemotherapy drugs and could form a basis for new oncology
drugs.
Degussa have discovered a catalyst that improves the efficiency of
reductive carbonylation reactions and will provide greater access
to new active pharmaceutical ingredients (APIs).
